We are live on ! Find out more
AKRO

Akero Therapeutics
AKRO

Delisted

AKRO was delisted on the 8th of December, 2025.

Back to rankings

257 hedge funds and large institutions have $4.92B invested in Akero Therapeutics in 2025 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 87 increasing their positions, 87 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more call options, than puts

Call options by funds: $100M | Put options by funds: $48.2M

46% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 39

40% more capital invested

Capital invested by funds: $3.5B → $4.92B (+$1.41B)

23% more funds holding in top 10

Funds holding in top 10: 13 → 16 (+3)

7% more funds holding

Funds holding: 240 → 257 (+17)

7.02% more ownership

Funds ownership: 108.56% → 115.58% (+7%)

0% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 87

Holders
257
Holders Change
+17
Holders Change %
+7.08%
% of All Funds
3.38%
Holding in Top 10
16
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+23.08%
% of All Funds
0.21%
New
57
Increased
87
Reduced
87
Closed
39
Calls
$100M
Puts
$48.2M
Net Calls
+$51.8M
Net Calls Change
+$37.2M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$159M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$100M
3
WP
Woodline Partners
California
+$90.3M
4
Holocene Advisors
Holocene Advisors
New York
+$48.9M
5
Bank of America
Bank of America
North Carolina
+$48.2M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$115M
2
RI
RTW Investments
New York
-$88.2M
3
SG Americas Securities
SG Americas Securities
New York
-$52.3M
4
Citadel Advisors
Citadel Advisors
Florida
-$33.6M
5
BlackRock
BlackRock
New York
-$21.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
A
176
AlphaQuest
New York
$383K -$111K -2,442 -25%
SFWA
177
Summit Financial Wealth Advisors
Louisiana
$382K – – –
AIP
178
Ameritas Investment Partners
Nebraska
$381K -$18.4K -406 -5%
DAM
179
DLD Asset Management
New York
$379K +$323K +7,107 New
TI
180
Trexquant Investment
Connecticut
$341K +$290K +6,383 New
Los Angeles Capital Management
181
Los Angeles Capital Management
California
$338K -$52.5K -1,155 -15%
Osaic Holdings
182
Osaic Holdings
Arizona
$336K -$7.27K -160 -2%
Canada Life
183
Canada Life
Manitoba, Canada
$334K +$99.6K +2,192 +54%
NSAM
184
North Star Asset Management
Wisconsin
$304K +$259K +5,700 New
X
185
Xponance
Pennsylvania
$292K -$4.59K -101 -2%
SG Americas Securities
186
SG Americas Securities
New York
$285K -$52.3M -1,150,442 -100%
LCM
187
Legato Capital Management
California
$284K +$242K +5,322 New
PA
188
Parallel Advisors
California
$276K -$136 -3 -0.1%
PWM
189
Palumbo Wealth Management
New York
$262K +$223K +4,910 New
Mackenzie Financial
190
Mackenzie Financial
Ontario, Canada
$256K +$218K +4,798 New
LPL Financial
191
LPL Financial
California
$256K -$65.2K -1,434 -23%
Tudor Investment Corp
192
Tudor Investment Corp
Connecticut
$249K -$1.83M -40,327 -90%
VPIM
193
Vanguard Personalized Indexing Management
California
$248K +$211K +4,654 New
CL
194
Choreo LLC
Illinois
$227K +$193K +4,246 New
Neuberger Berman Group
195
Neuberger Berman Group
New York
$219K +$187K +4,112 New
FCM
196
Farallon Capital Management
California
$213K +$182K +4,000 New
OF
197
Optimize Financial
California
$209K +$178K +3,920 New
NEI
198
Northwest & Ethical Investments
Ontario, Canada
$208K +$132K +2,900 +363%
Janney Montgomery Scott
199
Janney Montgomery Scott
Pennsylvania
$203K +$173K +3,810 New
EB
200
Eastern Bank
Massachusetts
$187K – – –
6 7
8
9 10

AKRO Hedge Fund Activity: Q2 2025 in Review

257 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Akero Therapeutics (AKRO) for Q2 2025, worth a combined $4.92B — up 40% from $3.5B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new AKRO positions and 39 closed out — a net gain of 18 holders — while 87 added to existing stakes and 87 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $159M. The largest seller was Wellington Management Group, cutting an estimated $115M.

  • 257 institutional investors held Akero Therapeutics (AKRO) as of Q2 2025, up from 240 in Q1 2025.
  • Funds reported $4.92B of Akero Therapeutics stock for Q2 2025, up 40% quarter-over-quarter.
  • 57 funds opened new Akero Therapeutics positions in Q2 2025 and 39 closed out, a net change of +18 holders.
  • The largest Akero Therapeutics buyer in Q2 2025 was Avoro Capital Advisors, an estimated $159M added.
  • The largest Akero Therapeutics seller in Q2 2025 was Wellington Management Group, an estimated $115M sold.

Based on aggregated 13F filings for Q2 2025.